These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 15753005)

  • 21. Approaches to achieve high-level heterologous protein production in plants.
    Streatfield SJ
    Plant Biotechnol J; 2007 Jan; 5(1):2-15. PubMed ID: 17207252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plant-based production of biopharmaceuticals.
    Fischer R; Stoger E; Schillberg S; Christou P; Twyman RM
    Curr Opin Plant Biol; 2004 Apr; 7(2):152-8. PubMed ID: 15003215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plant biopharming of monoclonal antibodies.
    Ko K; Koprowski H
    Virus Res; 2005 Jul; 111(1):93-100. PubMed ID: 15896408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic antibody production technologies: molecules, applications, expression and purification.
    Humphreys DP; Glover DJ
    Curr Opin Drug Discov Devel; 2001 Mar; 4(2):172-85. PubMed ID: 11378956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cell-free protein synthesis: applications in proteomics and biotechnology.
    He M
    N Biotechnol; 2008; 25(2-3):126-32. PubMed ID: 18786663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advances in antibody manufacturing using mammalian cells.
    Morrow KJ
    Biotechnol Annu Rev; 2007; 13():95-113. PubMed ID: 17875475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety assessment considerations for food and feed derived from plants with genetic modifications that modulate endogenous gene expression and pathways.
    Kier LD; Petrick JS
    Food Chem Toxicol; 2008 Aug; 46(8):2591-605. PubMed ID: 18602733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Plant as bioreactor].
    Yang J; Li T; Xiong L; Pang S; Li X
    Sheng Wu Gong Cheng Xue Bao; 2009 May; 25(5):650-7. PubMed ID: 19670631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biotechnology of flavonoids and other phenylpropanoid-derived natural products. Part II: Reconstruction of multienzyme pathways in plants and microbes.
    Ververidis F; Trantas E; Douglas C; Vollmer G; Kretzschmar G; Panopoulos N
    Biotechnol J; 2007 Oct; 2(10):1235-49. PubMed ID: 17935118
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Production of a monoclonal antibody in plants with a humanized N-glycosylation pattern.
    Schähs M; Strasser R; Stadlmann J; Kunert R; Rademacher T; Steinkellner H
    Plant Biotechnol J; 2007 Sep; 5(5):657-63. PubMed ID: 17678502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Engineered affinity proteins--generation and applications.
    Grönwall C; Ståhl S
    J Biotechnol; 2009 Mar; 140(3-4):254-69. PubMed ID: 19428722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glycosylation engineering in yeast: the advent of fully humanized yeast.
    Hamilton SR; Gerngross TU
    Curr Opin Biotechnol; 2007 Oct; 18(5):387-92. PubMed ID: 17951046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Manufacturing of recombinant therapeutic proteins in microbial systems.
    Graumann K; Premstaller A
    Biotechnol J; 2006 Feb; 1(2):164-86. PubMed ID: 16892246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plant protoplasts: status and biotechnological perspectives.
    Davey MR; Anthony P; Power JB; Lowe KC
    Biotechnol Adv; 2005 Mar; 23(2):131-71. PubMed ID: 15694124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic peptides: technological advances driving peptides into development.
    Sato AK; Viswanathan M; Kent RB; Wood CR
    Curr Opin Biotechnol; 2006 Dec; 17(6):638-42. PubMed ID: 17049837
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Production of recombinant proteins by microbes and higher organisms.
    Demain AL; Vaishnav P
    Biotechnol Adv; 2009; 27(3):297-306. PubMed ID: 19500547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Engineered antibodies accelerating drug discovery and development.
    Zhu Z
    IDrugs; 2001 Dec; 4(12):1346-8. PubMed ID: 15931562
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological significance of glycosylation in therapeutic proteins.
    Li H; d'Anjou M
    Curr Opin Biotechnol; 2009 Dec; 20(6):678-84. PubMed ID: 19892545
    [TBL] [Abstract][Full Text] [Related]  

  • 40. From Neanderthal to nanobiotech: from plant potions to pharming with plant factories.
    Sourrouille C; Marshall B; Liénard D; Faye L
    Methods Mol Biol; 2009; 483():1-23. PubMed ID: 19183890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.